Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: DM 913611-97-9
Purity: 99%
Appearence: White Powder
Packaging: As required
Transportation: Ocean,Air
Place of Origin: Hebei,China
Port: Shanghai,Shenzhen,Qingdao
Payment Type: L/C,T/T,D/P
Incoterm: FOB,CIF
High quality Brexpiprazole Cas 913611-97-9:
CAS No.: 913611-97-9
Name: Brexpiprazole
Other names: 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one;Brexpiprazole;
7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone;
7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one;
Molecular formula: C25H27N3O2S
Molecular weight :433.57
Storage:Keep in seal, try and cool place
Shelf life: 2 years
Brexpiprazole, sold under the brand name Rexulti, is an atypical antipsychotic. It is a dopamine D2 receptor partial agonistand has been described as a "serotonin–dopamine activity modulator" (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. It has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).
Product Categories : APIs And Intermediates > Brexpiprazole Intermediates
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.